Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/535 (2006.01) C07D 209/42 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2308443

The compound, ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2- methyl-1H-indol-4-yl)oxy)acetic acid morpholino-N-ethyl ester, is disclosed together with its use as a highly bioavailable indole compound for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.

L'invention concerne le composé d'ester de morpholino-N-éthyle d'acide ((3-(2-amino-1,2-dioxoéthyle)-1-((1,1'-biphényl)-3-ylméthyl)-2-méthyl-1H-indol-4-yl)oxy)acétique, ainsi que son utilisation en tant que composé indolique présentant une biodisponibilité élevée et servant à inhiber la libération provoquée par l'intermédiaire de sPLA¿2? d'acides gras afin de traiter des états tels que le choc septique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1830820

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.